Stockscreener 앱 받기
2.35
2.62%
0.06
전일 마감가:
$2.29
열려 있는:
$2.35
하루 거래량:
10,947
Relative Volume:
0.01
시가총액:
$31.88M
수익:
$37.79M
순이익/손실:
$-10.38M
주가수익비율:
-3.2192
EPS:
-0.73
순현금흐름:
$-1.00M
1주 성능:
-0.84%
1개월 성능:
+90.28%
6개월 성능:
+60.41%
1년 성능:
+4.91%
1일 변동 폭
$2.262
$2.375
1주일 범위
$2.18
$2.44
52주 변동 폭
$1.04
$3.05
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
명칭
Cumberland Pharmaceuticals Inc
전화
615-255-0068
주소
2525 WEST END AVENUE, NASHVILLE,, TN
CPIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
2.35 | 31.88M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
163.27 | 74.31B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.505 | 42.98B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.38 | 42.51B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.71 | 24.56B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
11.99 | 14.33B | 15.05B | -883.30M | 1.89B | -0.74 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2012-11-12 | 재확인 | UBS | Neutral |
| 2011-02-01 | 재확인 | UBS | Neutral |
| 2010-12-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2010-08-17 | 다운그레이드 | Jefferies | Buy → Hold |
| 2010-08-17 | 재확인 | Morgan Joseph | Buy |
| 2010-08-17 | 재확인 | UBS | Buy |
| 2010-05-14 | 재확인 | Morgan Joseph | Buy |
모두보기
Cumberland Pharmaceuticals Inc 주식(CPIX)의 최신 뉴스
Cumberland Pharmaceuticals (NASDAQ:CPIX) Coverage Initiated at StockNews.com - Defense World
Cumberland Pharmaceuticals director James Jones acquires $1,317 in stock By Investing.com - Investing.com Nigeria
Cumberland Pharmaceuticals CEO AJ Kazimi purchases $1317 in stock By Investing.com - Investing.com Nigeria
Cumberland Pharmaceuticals director Krogulski buys $8,209 in stock By Investing.com - Investing.com Canada
Cumberland Pharmaceuticals director Caroline Young acquires $256 in stock By Investing.com - Investing.com Canada
Cumberland Pharmaceuticals director Krogulski buys $8,209 in stock - Investing.com
Cumberland Pharmaceuticals director James Jones acquires $1,317 in stock - Investing.com India
Cumberland Pharmaceuticals CEO AJ Kazimi purchases $1317 in stock - Investing.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by StockNews.com - Defense World
Athira Pharma (NASDAQ:ATHA) Stock Quotes, Forecast and News Summary - Benzinga
StockNews.com Begins Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX) - Defense World
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
StockNews.com Initiates Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX) - Defense World
FDA APPROVES ACETADOTE® sNDA - Citizentribune
3 Promising Penny Stocks With Market Caps Under $2B In US - Simply Wall St
Cumberland Pharmaceuticals stock pops - Nashville Post
Cumberland Stock Soars 90% After FDA Approval for Acetadote Dosing Change - GuruFocus.com
Stock Skyrockets! Discover What’s Fueling This Company’s Massive Surge. - elblog.pl
Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings - Benzinga
Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday? - Benzinga
Cumberland Pharma Stock Hits 16-Month High After FDA Approves Liver Drug Regimen: Retail’s Thrilled - MSN
Cumberland (CPIX) Celebrates FDA Nod With Market Rally - Stocks Telegraph
FDA Approves Simplified Dosing For Cumberland's Acetadote - Contract Pharma
CPIX stock touches 52-week high at $2.92 amid market fluctuations - Investing.com
Cumberland Pharma Shares Rise 56% After FDA Approves Liver Drug Acetadote - MarketWatch
Cumberland Pharma Secures FDA Approval for Breakthrough Acetadote Dosing Innovation - StockTitan
Cumberland Pharmaceuticals director James Jones buys $1,754 in stock By Investing.com - Investing.com South Africa
Cumberland Pharmaceuticals CEO A.J. Kazimi buys $1,754 in stock - Investing.com India
Cumberland Pharmaceuticals director Caroline Young buys $755 in stock By Investing.com - Investing.com Nigeria
Cumberland Pharmaceuticals director Caroline Young buys $755 in stock - Investing.com
Cumberland Pharmaceuticals director James Jones buys $1,754 in stock - Investing.com
Cumberland Pharmaceuticals director Kenneth Krogulski buys $9,347 in stock - Investing.com
Cumberland Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 - Marketscreener.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Now Covered by Analysts at StockNews.com - Defense World
Cumberland Pharma stock hits 52-week low at $1.04 By Investing.com - Investing.com South Africa
Cumberland Pharma stock hits 52-week low at $1.04 - Investing.com
Newly Released Insights in to the Artificial Saliva Market Insights - WhaTech
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2024 Earnings Call Transcript - MSN
Corneal Ulcer Treatment Market 2034: Clinical Trials, Medication, Prevalence, Incidence, Therapies, EMA, PDMA, FDA Approvals, and Companies by DelveInsight - The Globe and Mail
Ibuprofen Injection Shows Better Real-World Outcomes in Comparative Study - Pharmacy Practice News
Cumberland Pharma stock hits 52-week low at $1.07 - Investing.com
Cumberland Pharma stock hits 52-week low at $1.07 By Investing.com - Investing.com UK
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by Cumberland Partners Ltd - MarketBeat
Ibuprofen injection exhibits kidney safety with cost benefits over ketorolac: Study - Medical Dialogues
Cumberland Pharmaceuticals Third Quarter 2024 Earnings: US$0.11 loss per share (vs US$0.073 loss in 3Q 2023) - Yahoo Canada Finance
Cumberland Pharmaceuticals Inc. (CPIX) Quarterly 10-Q Report - Quartzy
Cumberland Pharmaceuticals Inc (CPIX) Q3 2024 Earnings Call Highlights: Navigating Challenges ... By GuruFocus - Investing.com Canada
FDA Grants Orphan Drug Designation to Ifetroban for Treatment of Duchenne Muscular Dystrophy-Associated Cardiomyopathy - Pharmacy Times
Cumberland: Q3 Earnings Snapshot - mySA
Cumberland Pharmaceuticals Reports Q3 2024 Earnings and Developments - TipRanks
Cumberland Pharmaceuticals Inc (CPIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.17%
자본화:
|
볼륨(24시간):